209 related articles for article (PubMed ID: 23545288)
61. Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide.
Kuo YC; Lin CY
J Drug Target; 2015 Feb; 23(2):147-58. PubMed ID: 25268274
[TBL] [Abstract][Full Text] [Related]
62. Nanoparticle-mediated delivery of oligonucleotides to the blood-brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms.
Ko YT
J Drug Target; 2013 Nov; 21(9):866-73. PubMed ID: 23952765
[TBL] [Abstract][Full Text] [Related]
63. β-cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier.
Gil ES; Wu L; Xu L; Lowe TL
Biomacromolecules; 2012 Nov; 13(11):3533-41. PubMed ID: 23066958
[TBL] [Abstract][Full Text] [Related]
64. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.
Lien CF; Molnár E; Toman P; Tsibouklis J; Pilkington GJ; Górecki DC; Barbu E
Biomacromolecules; 2012 Apr; 13(4):1067-73. PubMed ID: 22409486
[TBL] [Abstract][Full Text] [Related]
65. P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.
Park S; Sinko PJ
J Pharmacol Exp Ther; 2005 Mar; 312(3):1249-56. PubMed ID: 15528451
[TBL] [Abstract][Full Text] [Related]
66. Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin.
Kuo YC; Chou PR
J Pharm Sci; 2014 Aug; 103(8):2484-97. PubMed ID: 25041794
[TBL] [Abstract][Full Text] [Related]
67. Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: Colocalization of ALDH and CD44.
Kuo YC; Wang LJ; Rajesh R
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():362-372. PubMed ID: 31147008
[TBL] [Abstract][Full Text] [Related]
68. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
[TBL] [Abstract][Full Text] [Related]
69. Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells.
Shah RM; Rajasekaran D; Ludford-Menting M; Eldridge DS; Palombo EA; Harding IH
Colloids Surf B Biointerfaces; 2016 Apr; 140():204-212. PubMed ID: 26764103
[TBL] [Abstract][Full Text] [Related]
70. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
[TBL] [Abstract][Full Text] [Related]
71. A novel biocompatible bicephalous dianionic surfactant from oleic acid for solid lipid nanoparticles.
Kalhapure RS; Akamanchi KG
Colloids Surf B Biointerfaces; 2013 May; 105():215-22. PubMed ID: 23376748
[TBL] [Abstract][Full Text] [Related]
72. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
73. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
74. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier.
Kuo YC; Lu CH
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):225-31. PubMed ID: 21524890
[TBL] [Abstract][Full Text] [Related]
75. Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
Kuo YC; Lee CH
J Pharm Sci; 2015 May; 104(5):1804-14. PubMed ID: 25694089
[TBL] [Abstract][Full Text] [Related]
76. Nicotine and cotinine increases the brain penetration of saquinavir in rat.
Manda VK; Mittapalli RK; Bohn KA; Adkins CE; Lockman PR
J Neurochem; 2010 Dec; 115(6):1495-507. PubMed ID: 20950334
[TBL] [Abstract][Full Text] [Related]
77. Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.
Jain R; Agarwal S; Majumdar S; Zhu X; Pal D; Mitra AK
Int J Pharm; 2005 Oct; 303(1-2):8-19. PubMed ID: 16137847
[TBL] [Abstract][Full Text] [Related]
78. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
[TBL] [Abstract][Full Text] [Related]
79. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
Dilnawaz F; Singh A; Mewar S; Sharma U; Jagannathan NR; Sahoo SK
Biomaterials; 2012 Apr; 33(10):2936-51. PubMed ID: 22264522
[TBL] [Abstract][Full Text] [Related]
80. Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells.
Kuo YC; Liang CT
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):131-7. PubMed ID: 21411296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
